Days after U.S. officials reported the first positive controlled data for Gilead’s remdesivir in COVID-19, the FDA has […]
Month: May 2020
There is never a good time for a pandemic, but covid-19 kicked doctors while we were down. Between […]
Doctors should reassure parents and carers of children who are immunocompromised that immunosuppression does not seem to increase […]
The only time that Denis Wirtz, vice provost for research at Johns Hopkins University in Baltimore, can find […]
AbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products […]
Gilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate […]
At the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO […]
Moderna Therapeutics has partnered with the federal government to create an mRNA-based COVID-19 vaccine it hopes to speed […]
FiercePharmaAsia—AZ’s COVID-hit China business; GSK’s $3.7B Unilever stake sale; I-Mab eyes $2B deal
AstraZeneca saw its China sales growth slow down in the first quarter, when the coronavirus outbreak was at […]
A research programme to determine the prevalence of covid-19 in the community and the proportion of the population […]